findmyKOL

Lisa Kosmiski, MD

Basic profile

University of Colorado Anschutz Medical Campus

ORCIDNone on fileNPI
RegionAurora, CO · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding1999–2012Why? →

Lisa Kosmiski is an Endocrinology/Metabolic physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 31 publications with 1,032 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

1,032citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4NIH grants · 1999–2012

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    53.5%
    GLP-1 receptor agonist17.2%
    Trulicity75%Ozempic18%Victoza 3-Pak7%
    Part D<11 patients
    Insulin Analog11.3%
    Lantus Solostar29%Novolog Flexpen27%Levemir Flexpen20%Humalog Kwikpen U-10014%Toujeo Solostar10%
    Part D<11 patients

    + 7 more classes in this area

  • Cardiovascular

    20.8%
    Statin9.7%
    Atorvastatin Calcium55%Rosuvastatin Calcium45%
    Part D23 patients
    ACE inhibitor4.5%
    Lisinopril100%
    Part D17 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    17.6%
    l-Thyroxine10.1%
    Levothyroxine Sodium100%
    Part D25 patients
    Thyroid Hormone Synthesis Inhibitor6.2%
    Methimazole100%
    Part D20 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 19992012 per NIH RePORTER. The latest:

25 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”